Chief Executive James McLaughlin is lacing up his trainers once more for one final run, taking on his toughest test yet—running over 10 marathons in 14 days for a total of 270 miles with no rest days, running through 29 blood cancer centres across the UK where the charity supports through clinical trials networks
George Lineker, entrepreneur and long-time supporter of Cure Leukaemia, will once again take on the epic London 2 Paris cycling challenge this June, marking a decade since he first completed the ride in 2015, raising vital funds for Cure Leukaemia.
On World Blood Cancer Day, we stand in solidarity with patients, families, researchers, and healthcare professionals who are fighting to change that.
After living cancer-free for 15 years, Rob faced two devastating relapses of stage 4 lymphoma. The thought of enduring another six months of chemotherapy was overwhelming — until he was offered a place on the ZUMA-22 clinical trial, exploring the use of CAR-T cell therapy for relapsed lymphoma patients.
Amelie was three when she was first diagnosed with leukaemia. Ten years and four relapses later, she’s finally ready for a new beginning.
On International Clinical Trials Day, Cure Leukaemia celebrates the life-saving difference that clinical trials make to people living with blood cancer
Jonathan’s experience with the TAP-funded FEDORA Clinical Trial didn’t just improve his health—it gave him a second chance at life, highlighting the life-changing potential of clinical trials for patients with limited treatment options.
